SELZENTRY (maraviroc) Viiv hlthcare Patent: 7,368,460 Expiration: May 25, 2023 See More … For more information on how DrugPatentWatch can […]
Drug Patent Expirations for the Week of May 21, 2023 Read Post »
SELZENTRY (maraviroc) Viiv hlthcare Patent: 7,368,460 Expiration: May 25, 2023 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of May 21, 2023 Read Post »
Annual Drug Patent Expirations for PROMACTA Promacta is a drug marketed by Novartis and is included in two NDAs. It
New patent expiration for Novartis drug PROMACTA Read Post »
Annual Drug Patent Expirations for PROMACTA+KIT Promacta Kit is a drug marketed by Novartis and is included in one NDA.
New patent expiration for Novartis drug PROMACTA KIT Read Post »
Annual Drug Patent Expirations for NAROPIN Naropin is a drug marketed by Fresenius Kabi Usa and is included in one
New patent expiration for Fresenius Kabi drug NAROPIN Read Post »
Annual Drug Patent Expirations for AMTURNIDE Amturnide is a drug marketed by Novartis and is included in one NDA. There
New patent expiration for Novartis drug AMTURNIDE Read Post »
Annual Drug Patent Expirations for EXFORGE+HCT Exforge Hct is a drug marketed by Novartis and is included in one NDA.
New patent expiration for Novartis drug EXFORGE HCT Read Post »
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It
Annual Drug Patent Expirations for BANZEL Banzel is a drug marketed by Eisai Inc and is included in two NDAs.
Get fresh news and insights, drug patent expirations & more…
